Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic study on human skin samples: identification of actinic keratoses two risk classes.

ABSTRACT: Transcriptomic study on human skin samples: identification of actinic keratoses two risk classes.

PROVIDER: PRJNA857002 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Human normal and actinic keratosis skin rRNA samples

Project description:Topical probiotics for actinic keratoses: Alteration of actinic keratoses microbiome to reduce the risk of malignant progression.

| PRJNA1048547 | ENA

Transcriptomic study on human skin samples: identification of actinic keratoses two risk classes.

Project description:Gene expression profile analysis allowed to identify 2 classes of AK.

2023-03-19 | GSE207744 | GEO

GZ21T inhibits the growth of actinic keratoses in a UVB induced model of skin carcinogenesis

Project description:To investigate the mechanism behind GZ21T's ability to inhibit actinic keratoses growth in an ultra-violet B induced model of skin carcinogenisis

2023-02-02 | GSE223986 | GEO

Bulk RNA-Seq of actinic keratoses

Project description:RNA-Seq was performed on 8 actinic keratoses (AK) to identify differentially expressed genes in AK vs normal skin and cutaneous squamous cell carcinoma

2024-04-08 | GSE261645 | GEO

Bulk RNA-Seq of actinic keratoses

Project description:Bulk RNA-Seq of actinic keratoses

| PRJNA1088157 | ENA

T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions

Project description:Actinic keratoses were treated with either calcipotriol plus 5-FU or vaseline plus 5-FU in the randomized clinical trial. We have Day 0 before treatment samples and Day 5 after treatment samples in two groups.

2024-12-20 | GSE255479 | GEO

A molecular signature for rejuvenation characterizes lesional and non lesional skin following Metvix treatment in Actinic Keratosis patients.

Project description:Actinic keratoses (AK) are proliferations of pre-neoplastic keratinocytes in the epidermis that are the result of cumulative ultraviolet (UV) radiations from sun exposure. Lesions are commonly found on sites of sun-exposed skin such as the face, balding scalp, and back of the hand. AKs may present on a patient as a few detectable lesions and 5-10% of them are susceptible to transform into SCC. In contrast, Organ Transplant Recipients (OTR) are of increasing risk at developing cancers as a consequence of long-term immunosuppressive therapy. The molecular changes that occur in lesional and perilesional skin of OTR patients 18 weeks following of PDT with topical MAL treatment were investigated to better understand the effect of the therapeutic intervention on the AK lesions. Our data show the complete normalization of the skin biology in the treated areas, i. e restoration of normal proliferation related gene profiles, and correction of aberrantly expressed cancer associated genes. We were also able to uncover a transcriptional signature of a rejuvenation effect induced by MAL-PDT in photodamaged skin opening new avenues in the use of PTD for treating photodamaged skin and field cancerized areas.

2018-06-15 | GSE90643 | GEO

Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel

Project description:Actinic keratosis is a common skin disease that may progress to invasive squamous cell carcinoma. Ingenol mebutate has demonstrated efficacy in field treatment of actinic keratosis. However, molecular mechanisms on ingenol mebutate response are not yet fully understood.

2020-05-18 | GSE142108 | GEO

GZ21T inhibits the growth of actinic keratoses in a UVB induced model of skin carcinogenesis

Project description:GZ21T inhibits the growth of actinic keratoses in a UVB induced model of skin carcinogenesis

| PRJNA929265 | ENA

Genome-wide SNP analysis of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients

Project description:The risk of developing cutaneous squamous cell carcinoma (SCC) is markedly increased in organ transplant recipients (OTRs) compared to the normal population. Next to sun exposure, the immunosuppressive regimen is an important risk factor for SCC development in OTRs. Various gene mutations (e.g. TP53) and genetic alterations (e.g. CDKN2A loss, RAS amplification) have been found in SCCs. The aim of this study was to identify genomic alterations that are consistently involved in the formation of SCCs and their precursor lesions, actinic keratoses (AKs). To perform the analysis in an isogenic background, DNA was isolated from SCC and AK from each of 13 OTRs. Tumor samples and their matching normal control (peripheral blood) were analyzed on the Illumina HumanHap550V3_duo genotyping beadchips. In contrast to previous studies, genome-wide SNP analysis showed very few copy number variations in AKs and SCCs, and these variations had no apparent relationship with observed changes in mRNA expression profiles (GSE32628). Other molecular mechanisms, such as DNA methylation or miRNA alterations, may affect gene expression in SCCs of OTRs.

2013-02-06 | GSE32969 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data